The 2023 Cell and Gene Industry Exchange Meeting kicked off in Dapeng New District on Saturday. The meeting also marked the opening of Shenzhen Zeyi Cell Therapy Co. During the event, Zeyi collaborated with Nobel Prize winners, academicians, top-notch scientists and medical experts to launch a scientific program called Tian Nian Health Stem Cell.

Zeyi is a comprehensive platform that encompasses a cell therapy research institute, a tech innovation center in cooperation with Nobel Prize winners, a cell freeze bank and clinics. The company is dedicated to the rapid development of the cell therapy field and innovative solutions for cancer prevention.

The 2023 Cell and Gene Industry Exchange Meeting kicked off in Dapeng New District on Saturday. Photos from Shenzhen TV 

Dapeng New District has actively developed industrial clusters in biomedicine, health, synthetic biology, as well as cell and gene industries.

Bai Zongke, president of Shenzhen Zeyi Cell Therapy Co., highlighted three reasons for choosing to settle in Dapeng. First, the new area offered favorable measures, with efficient handling of matters by government departments and corresponding guidance for innovative industries. Second, Dapeng’s location provides a suitable environment for scientific research, surrounded by mountains and seas, away from the bustling downtown. Third, the area has taken measures to address the concerns of scientists and their families, such as assistance in enrolling their children in local schools.

Bai expressed during the meeting that their goal is to establish a world-class cancer control and prevention center.

The inauguration ceremony of Shenzhen Zeyi Cell Therapy Company. 

Statistics showed a significant increase in the number of newly diagnosed cancer cases among individuals aged 50 and below, reaching 1.82 million, a 79% increase from 1990. Predications indicated that the number of new cancer patients will continue to rise by 2030.

In order to combat cancer, Zeyi has joined forces with Nobel Prize winners, academicians, top-notch scientists and medical experts to launch the Tian Nian Health Stem Cell, which aims to extend people's life expectancy through precise cell therapy within 20 years.

Cui Baoshan from the China Health Promotion Foundation Cancer Control and Prevention Project, introduced that the program was initiated in 2000 when academician Wu Mengchao proposed the concept of cell therapy.

When discussing the attractiveness of Shenzhen, Michael Levitt, winner of the 2013 Nobel Prize for Chemistry, expressed, "I have been to many places in China, and this is my fifth time in Shenzhen. I think Shenzhen is unique due to its favorable location. Shenzhen is an innovative city that serves as a testing ground for new ideas and measures. Moreover, Shenzhen is leading the way in the biomedicine industry, which will greatly benefit the industry's development."

Michael Levitt, winner of the 2013 Nobel Prize for Chemistry, gives a speech. 

Arieh Warshel, another winner of the Nobel Prize for Chemistry and a professor at the Chinese University of Hong Kong, stated, "Shenzhen is a young city that attracts young talents. It has achieved remarkable progress in technological research in biomedicine and related fields." Warshel, who has been in Shenzhen since 2014 and witnessed its development, added, "I have witnessed firsthand the rapid growth of Shenzhen. It is a great place."